152 related articles for article (PubMed ID: 31974652)
1. Repression of oncogenic cap-mediated translation by 4Ei-10 diminishes proliferation, enhances chemosensitivity and alters expression of malignancy-related proteins in mesothelioma.
Ahmad Z; Jacobson BA; McDonald MW; Vattendahl Vidal N; Vattendahl Vidal G; Chen S; Dillenburg M; Okon AM; Patel MR; Wagner CR; Kratzke RA
Cancer Chemother Pharmacol; 2020 Feb; 85(2):425-432. PubMed ID: 31974652
[TBL] [Abstract][Full Text] [Related]
2. Small-molecule inhibition of oncogenic eukaryotic protein translation in mesothelioma cells.
Chen EZ; Jacobson BA; Patel MR; Okon AM; Li S; Xiong K; Vaidya AJ; Bitterman PB; Wagner CR; Kratzke RA
Invest New Drugs; 2014 Aug; 32(4):598-603. PubMed ID: 24711125
[TBL] [Abstract][Full Text] [Related]
3. Targeting eukaryotic translation in mesothelioma cells with an eIF4E-specific antisense oligonucleotide.
Jacobson BA; Thumma SC; Jay-Dixon J; Patel MR; Dubear Kroening K; Kratzke MG; Etchison RG; Konicek BW; Graff JR; Kratzke RA
PLoS One; 2013; 8(11):e81669. PubMed ID: 24260583
[TBL] [Abstract][Full Text] [Related]
4. 4Ei-10 interdiction of oncogenic cap-mediated translation as therapy for non-small cell lung cancer.
Jacobson BA; Ahmad Z; Chen S; Waldusky G; Dillenburg M; Stoian E; Cambron DA; Patel AJ; Patel MR; Wagner CR; Kratzke RA
Invest New Drugs; 2021 Jun; 39(3):636-643. PubMed ID: 33230623
[TBL] [Abstract][Full Text] [Related]
5. Treatment of breast and lung cancer cells with a N-7 benzyl guanosine monophosphate tryptamine phosphoramidate pronucleotide (4Ei-1) results in chemosensitization to gemcitabine and induced eIF4E proteasomal degradation.
Li S; Jia Y; Jacobson B; McCauley J; Kratzke R; Bitterman PB; Wagner CR
Mol Pharm; 2013 Feb; 10(2):523-31. PubMed ID: 23289910
[TBL] [Abstract][Full Text] [Related]
6. 4EGI-1 represses cap-dependent translation and regulates genome-wide translation in malignant pleural mesothelioma.
De A; Jacobson BA; Peterson MS; Jay-Dixon J; Kratzke MG; Sadiq AA; Patel MR; Kratzke RA
Invest New Drugs; 2018 Apr; 36(2):217-229. PubMed ID: 29116477
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of oncogenic cap-dependent translation by 4EGI-1 reduces growth, enhances chemosensitivity and alters genome-wide translation in non-small cell lung cancer.
De A; Jacobson BA; Peterson MS; Stelzner ME; Jay-Dixon J; Kratzke MG; Patel MR; Bitterman PB; Kratzke RA
Cancer Gene Ther; 2019 May; 26(5-6):157-165. PubMed ID: 30420719
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of autophagy potentiates pemetrexed and simvastatin-induced apoptotic cell death in malignant mesothelioma and non-small cell lung cancer cells.
Hwang KE; Kim YS; Jung JW; Kwon SJ; Park DS; Cha BK; Oh SH; Yoon KH; Jeong ET; Kim HR
Oncotarget; 2015 Oct; 6(30):29482-96. PubMed ID: 26334320
[TBL] [Abstract][Full Text] [Related]
9. Translation initiation complex eIF4F is a therapeutic target for dual mTOR kinase inhibitors in non-Hodgkin lymphoma.
Demosthenous C; Han JJ; Stenson MJ; Maurer MJ; Wellik LE; Link B; Hege K; Dogan A; Sotomayor E; Witzig T; Gupta M
Oncotarget; 2015 Apr; 6(11):9488-501. PubMed ID: 25839159
[TBL] [Abstract][Full Text] [Related]
10. Targeting the eIF4F translation initiation complex for cancer therapy.
Konicek BW; Dumstorf CA; Graff JR
Cell Cycle; 2008 Aug; 7(16):2466-71. PubMed ID: 18719377
[TBL] [Abstract][Full Text] [Related]
11. 2-Deoxy-glucose Enhances the Effect of Cisplatin and Pemetrexed in Reducing Malignant Pleural Mesothelioma Cell Proliferation But Not Spheroid Growth.
Gerogianni I; Pitaraki E; Jagirdar RM; Kouliou O; Giannakou L; Giannopoulos S; Papazoglou E; Hatzoglou C; Gourgoulianis KI; Zarogiannis SG
Anticancer Res; 2019 Jul; 39(7):3809-3814. PubMed ID: 31262908
[TBL] [Abstract][Full Text] [Related]
12. eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies.
Boussemart L; Malka-Mahieu H; Girault I; Allard D; Hemmingsson O; Tomasic G; Thomas M; Basmadjian C; Ribeiro N; Thuaud F; Mateus C; Routier E; Kamsu-Kom N; Agoussi S; Eggermont AM; Désaubry L; Robert C; Vagner S
Nature; 2014 Sep; 513(7516):105-9. PubMed ID: 25079330
[TBL] [Abstract][Full Text] [Related]
13. Eukaryotic translation initiation factor 4E availability controls the switch between cap-dependent and internal ribosomal entry site-mediated translation.
Svitkin YV; Herdy B; Costa-Mattioli M; Gingras AC; Raught B; Sonenberg N
Mol Cell Biol; 2005 Dec; 25(23):10556-65. PubMed ID: 16287867
[TBL] [Abstract][Full Text] [Related]
14. Ribavirin Inhibits the Activity of mTOR/eIF4E, ERK/Mnk1/eIF4E Signaling Pathway and Synergizes with Tyrosine Kinase Inhibitor Imatinib to Impair Bcr-Abl Mediated Proliferation and Apoptosis in Ph+ Leukemia.
Shi F; Len Y; Gong Y; Shi R; Yang X; Naren D; Yan T
PLoS One; 2015; 10(8):e0136746. PubMed ID: 26317515
[TBL] [Abstract][Full Text] [Related]
15. A novel inhibitor of cap-dependent translation initiation in yeast: p20 competes with eIF4G for binding to eIF4E.
Altmann M; Schmitz N; Berset C; Trachsel H
EMBO J; 1997 Mar; 16(5):1114-21. PubMed ID: 9118949
[TBL] [Abstract][Full Text] [Related]
16. Vesicular stomatitis virus infection alters the eIF4F translation initiation complex and causes dephosphorylation of the eIF4E binding protein 4E-BP1.
Connor JH; Lyles DS
J Virol; 2002 Oct; 76(20):10177-87. PubMed ID: 12239292
[TBL] [Abstract][Full Text] [Related]
17. Cap-dependent mRNA translation and the ubiquitin-proteasome system cooperate to promote ERBB2-dependent esophageal cancer phenotype.
Issaenko OA; Bitterman PB; Polunovsky VA; Dahlberg PS
Cancer Gene Ther; 2012 Sep; 19(9):609-18. PubMed ID: 22767218
[TBL] [Abstract][Full Text] [Related]
18. Antisense oligonucleotide targeting eukaryotic translation initiation factor 4E reduces growth and enhances chemosensitivity of non-small-cell lung cancer cells.
Thumma SC; Jacobson BA; Patel MR; Konicek BW; Franklin MJ; Jay-Dixon J; Sadiq A; De A; Graff JR; Kratzke RA
Cancer Gene Ther; 2015 Aug; 22(8):396-401. PubMed ID: 26227824
[TBL] [Abstract][Full Text] [Related]
19. Protein phosphatase 2A negatively regulates eukaryotic initiation factor 4E phosphorylation and eIF4F assembly through direct dephosphorylation of Mnk and eIF4E.
Li Y; Yue P; Deng X; Ueda T; Fukunaga R; Khuri FR; Sun SY
Neoplasia; 2010 Oct; 12(10):848-55. PubMed ID: 20927323
[TBL] [Abstract][Full Text] [Related]
20. Pemetrexed induces apoptosis in malignant mesothelioma and lung cancer cells through activation of reactive oxygen species and inhibition of sirtuin 1.
Hwang KE; Kim YS; Hwang YR; Kwon SJ; Park DS; Cha BK; Kim BR; Yoon KH; Jeong ET; Kim HR
Oncol Rep; 2015 May; 33(5):2411-9. PubMed ID: 25738249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]